Acumen Pharmaceuticals (NASDAQ: ABOS)
1 known investors
Acumen is a biopharmaceutical company developing targeted therapies for Alzheimer's disease. It focuses on advancing treatment outcomes in the neurodegenerative disease field.
1 known investors
Acumen is a biopharmaceutical company developing targeted therapies for Alzheimer's disease. It focuses on advancing treatment outcomes in the neurodegenerative disease field.